Brain Canada: Advancing Research On Care and Outcome Measurement 2.0

Sponsor

Brain Canada Foundation and Alzheimer’s Association (ALZ) 

For More Information

For additional information, please see the attached Request for Application document or the Alzheimer's Association website for

• Program guidelines
• LOI and Application instructions
• Evaluation criteria

Description

Brain Canada is pleased to be partnering with Alzheimer’s Association (ALZ) to launch the Advancing Research on Care and Outcome Measurement 2.0 (ARCOM-2) funding program, an international and collaborative competition aimed at addressing significant gaps in care and outcome measurement and providing an opportunity to advance research so that care providers can ensure that they are implementing evidence-based practices and achieving desired outcomes.

Areas of interest for this program include, but are not limited to, care preferences, behavioral expressions, quality metrics, and systems of care in the area of Alzheimer’s or other dementia. Through this partnership, Brain Canada will co-fund up to five (5) successful Canadian-led teams who meet peer review recommendations.

Eligibility

Only established, independent investigators are eligible as evidenced by:

•  Academic appointment (Assistant Professor and above or the equivalent at your institution);   
•  Major, peer-reviewed, external multi-year grant support on which the applicant is the principal investigator (PI); and
•  Quality and independence of publication record 

In general, scientists and clinicians from public, private, domestic and foreign research laboratories, medical centers, hospitals and universities are eligible to apply. State and federal government-appropriated laboratories in the U.S. and abroad and for-profit organizations are prohibited from serving as the applicant institution. For U.S. VA-based investigators, please work with your affiliated non-profit organization to apply.  In other circumstances, state and federal government scientists can participate as collaborating scientists with research teams from other eligible applicant institutions. 

For US entities, the Letter of Intent (LOI) materials will include proof of your organization‘s not-for-profit status and a W9 signed and dated by the signing official. Non-US entities must provide a W8-BEN-E signed and dated by the signing official.   

Your LOI will not be accepted without these documents (IRS Letter of Determination is no longer accepted). For non-profit organizations (non-academic), additional documentation may be required to confirm your organization has segregation of duties between transaction execution and transaction utilization. 

The Alzheimer’s Association reserves the right to request additional documentation and/or materials to verify an applicant’s status should any of the eligibility requirements be unconfirmed. 

Overlapping funding of more than one Alzheimer's Association grant is not allowed.

Funding Availability

up to 5 successful applications from Canadian-led teams

Maximum Project Value

$250,000USD (direct and indirect costs) per award

Indirect Costs

10%

Project Duration

up to 2 years

Special Notes

COVID-19

Please note that research activities carried out in the context of COVID-19 need to adhere to the University of Guelph COVID-19 research principles, policies, guidelines and processes as they may be updated from time to time and communicated on the Office of Research web-page.

Attachment(s)

Attachment	Size
Request for Application	744.33 KB